HYPD insider trading
NasdaqCM HealthcareHYPERION DEFI, INC.: insider trade history from SEC Form 4 filings.
About HYPERION DEFI, INC.
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.
Company website: hyperiondefi.com
HYPD insider activity at a glance
FilingIQ tracks 35 insider transactions for HYPD in filings since Jul 9, 2025. The most recent transaction is dated Sep 29, 2026.
Across the full history, 13 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on HYPD insider trades is 55.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest HYPD Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for HYPD?
- FilingIQ tracks 35 Form 4 insider transactions for HYPD (HYPERION DEFI, INC.), covering filings from Jul 9, 2025 onwards. 2 of those are dated within the last 90 days.
- Are HYPD insiders net buyers or net sellers?
- Across the full Form 4 history for HYPD, 13 transactions (37%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does HYPD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is HYPD in?
- HYPERION DEFI, INC. (HYPD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $29.15M.
Methodology & sources
Every HYPD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.